Support after your prescription
sipra medical team
Physician-reviewed
A man fills out an online form, has a three-minute call, and a box of medication shows up a week later. He starts the shots. By week four the nausea is rough and he is not sure if that is normal or a reason to stop. He logs back in to ask. There is no one there. No message thread, no nurse line, no follow-up appointment, just a renewal date and a charge that keeps coming. He is holding a real prescription and standing completely alone with it. That gap, the silence after the box arrives, is the thing we built sipra to close.
The short answer
Ongoing support after your prescription means the care does not end when the prescription ships. Good treatment with GLP-1 medication or hormone therapy needs dose adjustments, side-effect help, periodic lab checks, and a clear bill you can read. A provider who disappears after writing the script is not finished with the job.
What you will learn
- What the post-prescription support gap is, and why researchers have started naming it
- What ongoing care should actually include, in plain terms
- Why follow-up and dose titration are not optional extras
- When lab monitoring matters, and what gets checked
- What honest billing looks like, and what to watch for
- A short list of things to demand from any provider, sipra included
Chapter 01 · The problem
The gap nobody warns you about
There is a pattern in direct-to-consumer telehealth that has become common enough to have a name. You answer a questionnaire, maybe have a brief video or phone visit, and a prescription is issued. Then the relationship goes quiet. The medication keeps arriving and the card keeps getting charged, but the clinical part, the part where someone is actually watching how you are doing, never really starts.
A 2026 paper in the Journal of Medical Internet Research describes exactly this and calls it "the clinical support gap in telehealth-based GLP-1 care." The authors document patients who had no contact with a provider beyond a single short call when the medication was first ordered, and nothing after that.1
Why does it happen? The prescribe-and-disappear model is cheaper to run. A questionnaire and a quick visit can be heavily automated. Real follow-up, with people who answer messages and clinicians who adjust doses, costs money and does not scale as neatly. So some services optimize for the part that is easy to sell, the prescription, and quietly skip the part that is hard to staff, the support.
Roughly half of patients who start a GLP-1 medication stop within a year, often because of side effects or simply having no one to call when something feels off.
Medscape raised the same concern in its coverage of how these drugs get prescribed, noting that patients without proper follow-up may struggle with titration and with tapering off safely when the time comes.2 When we talk about staying with you after the prescription, we are pointing straight at this gap. It is the whole reason this commitment exists.
Chapter 02 · The standard
What ongoing care should actually include
Strip away the marketing language and ongoing care is a short, concrete list. For the categories sipra works in, GLP-1 weight treatment and hormone therapy among them, it looks like this:
CLINICIAN ACCESS
A way to reach a clinician between visits. Not a chatbot that closes the ticket. A message thread where a real person reads what you wrote and answers.
DOSE ADJUSTMENTS
Dose changes based on how you are doing. Your starting dose is a starting point, not a verdict. If the current dose is not working or not tolerated, it should change.
SIDE-EFFECT HELP
Side-effect management. Someone who can tell you whether what you are feeling is expected, manageable, or a reason to pause and reassess.
LAB MONITORING
Lab work at the right intervals. Baseline before you start, then follow-up checks on a schedule that fits the medication and the therapy.
A STOPPING PLAN
A plan for stopping. Including how to taper if and when that is appropriate, and who decides. A provider with no off-ramp has not planned for your long-term health.
READABLE BILLING
Billing you can actually understand. Every charge explained before it happens. The full cost shown up front, not discovered later on a statement.
None of this is exotic. It is ordinary good medicine, the kind you would expect from a clinic you walk into. The only thing notable about it is how often the online version leaves it out.
“Writing the prescription is maybe ten percent of the work. The other ninety percent is the months that follow, the dose changes, the questions at 9 p.m., the lab that came back a little off. A provider who hands you a script and goes quiet has skipped the part that actually decides how you do. We stay with you for the ninety percent.”sipra medical team
Chapter 03 · The ramp
Follow-up and titration: why the slow ramp matters
With GLP-1 medications like semaglutide and tirzepatide, the dose is increased gradually over weeks. This is called titration, and it is not a formality. The slow ramp gives your body time to adjust to the drug's effect on the gut, which is where most of the early side effects come from.
Gastrointestinal side effects, nausea, vomiting, diarrhea, are most likely during the start of treatment and the dose-escalation phase. The clinical playbook for handling them is specific. A clinician can hold the dose where it is, extend a phase for a few weeks, skip the next increase until symptoms settle, or step back to a lower dose and re-escalate more slowly. Each dose increase should happen only if the current one is well tolerated.
None of those titration moves work if no one is paying attention. Titration is the part of GLP-1 care most likely to go wrong without follow-up.
Notice what every one of those moves requires: a clinician who knows how you are doing right now. This is the mechanical reason the support gap matters so much. The prescribe-and-disappear model is least equipped to handle the part of care that needs the most attention. Individual results vary, and how a given person tolerates the ramp varies too, which is exactly why a fixed schedule mailed to your door is not the same as care. This is educational context, not a dose or diagnostic instruction. A licensed clinician decides titration for you.
Chapter 04 · The checks
Lab monitoring: the checks that should not be skipped
Hormone therapy makes the case for monitoring even more plainly. Responsible online hormone care does not start without current lab data, and it does not run on autopilot after that.
For men on testosterone, monitoring typically includes total testosterone, hematocrit (because testosterone can push red blood cell counts up), PSA, and a lipid panel, checked every three to six months at first, then every six to twelve months once things are stable. The Endocrine Society also flags watching for sleep apnea symptoms, which testosterone can worsen.3 For women on combined hormone therapy, progesterone monitoring matters for protecting the endometrium and managing breakthrough bleeding.
The pattern is the same across both: baseline labs before starting, follow-up testing a few weeks after you begin or after any dose change, then a steady cadence after that. A provider who prescribes hormones without a recent lab and never asks for another one is not monitoring you. They are guessing, and asking you to guess along with them.
| Prescribe-and-disappear | Supported care | |
|---|---|---|
| After the box ships | Silence until renewal | Scheduled check-ins and open messaging |
| Dose changes | Fixed schedule, no review | Adjusted to how you tolerate it |
| Side-effect help | You are on your own | A clinician reviews and responds |
| Lab monitoring | Often none after baseline | Baseline plus follow-up on a set cadence |
| Stopping treatment | No plan offered | A taper plan when appropriate |
| Billing | Surprise charges, hard to cancel | Full cost shown up front, cancel at any time |
| When something feels wrong | No one answers | Someone does |
Individual results vary. This table describes care models, not outcome guarantees. Swipe to see the full table on a phone.
Chapter 05 · The bill
Billing that does not punish you for staying
The support gap has a financial twin. The same model that goes quiet on the clinical side often gets very loud on the billing side, with charges that are hard to predict and subscriptions that are hard to leave.
The Federal Trade Commission has reported receiving roughly 70 consumer complaints a day about recurring charges that were either hard to cancel or that people did not realize they had agreed to, up from about 42 a day a few years earlier. The principle behind the FTC's negative-option work is simple and worth holding any provider to: all the material terms, including the full cost, should be disclosed clearly before you hand over your payment information, and canceling should be as easy as signing up was.4
Honest billing is part of staying with you. A bill you cannot read is its own kind of disappearing.
That is the standard any good provider should meet. It means the total cost is shown before you check out, not discovered later on a statement. It means no charge lands without you knowing what it is for. And it means leaving is a button, not a phone call you have to win an argument to end.
Chapter 06 · The commitment
Where sipra fits in all of this
We made ongoing support after your prescription our brand promise before we wrote a word of this, because the gap above is the problem we set out to solve. sipra connects you with licensed US physicians for GLP-1 weight treatment and six other therapy categories, and the part we care about most is everything that happens after the prescription: the follow-up, the dose adjustments, the lab checks, the message that gets answered, the bill you can read.
But we would rather you treat this as a standard than a sales pitch. The list in this article is the one to hold up against any provider you consider, ours included. If a service cannot show you how it handles titration, when it checks your labs, how you reach a clinician, and exactly what you will be charged, that tells you something before you ever sign up.
NO CHARGE UNTIL APPROVED
sipra does not charge you until your physician approves your treatment plan. You can cancel at any time. The full cost is shown before you pay.
Before you start anything, ask three things
The silence after the box arrives is avoidable. You just have to know to look for it before you sign up, not after.
- Ask who answers. Before you pay, find out exactly how you reach a clinician between visits and how fast they respond.
- Ask about labs and dose changes. A provider who cannot describe their monitoring schedule and their plan for adjusting your dose has not planned to do it.
- Read the full cost out loud. Make the total price and the cancellation steps appear before you enter a card. If they will not show you, that is your answer.
Take control of your health.
Frequently asked questions
Sources
- Journal of Medical Internet Research. "The clinical support gap in telehealth-based GLP-1 care." 2026. jmir.org
- Medscape. "GLP-1 Prescribing and the Follow-Up Problem in Telehealth." 2025. medscape.com
- The Endocrine Society. "Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline." Accessed June 2026. endocrine.org
- U.S. Federal Trade Commission. "Negative Option Rule." Accessed June 2026. ftc.gov
Medically reviewed by
sipra medical team
Was this helpful?
Keep reading
CompanyHow to Choose a Telehealth Provider You Can Trust: A 2026 Buyer's Checklist
16 min read
Men's HealthErectile dysfunction treatment in 2026: the full menu, from pills to the combo approach
19 min read
Weight LossGLP-1 weight loss 101: how semaglutide and tirzepatide actually work
17 min read
Weight LossHow GLP-1 Treatment With sipra Works, Step by Step
16 min read
Women's HealthMenopause and perimenopause: what changes, when, and what actually helps
17 min read
Weight LossThe Real Cost of GLP-1 Medication: Every Number Before Your Card Is Charged
16 min read
Weight LossBranded vs compounded GLP-1s: the real difference in 2026
9 min read
Weight LossGLP-1 Myths That Won't Die (and the Facts That Beat Them)
9 min read